Dolutegravir 50 mg , Tenofovir disoproxil Fumarate 300 mg and Lamivudine 300 mgTablets
/Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets
antiretroviral medications widely used in HIV management and combination therapy. Each tablet plays a distinct role in viral suppression while complementing the others for optimal therapeutic outcomes.
At Kureasia Pharma, we provide contract and third-party manufacturing of Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets, ensuring WHO-GMP certified quality, bulk production, and customized packaging.
Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets – Overview and Benefits
Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets are used individually or in combination for effective HIV treatment.
Key Benefits:
Once-daily dosing for patient convenience
High bioavailability and efficacy
WHO-GMP certified production for consistent quality
Suitable for contract and third-party bulk manufacturing
| Tablet Name | Strength | Dosage Form | Certification | Manufacturing Type | Packaging Options | Quality Assurance |
|---|---|---|---|---|---|---|
| Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets | 50 mg, 300 mg, 300 mg | Tablets | WHO-GMP Certified | Contract & Third-Party | Blister Packs, Bottles, Bulk | Multi-level QC checks |
Contract & Third-Party Manufacturing Services
Kureasia Pharma offers comprehensive manufacturing solutions for Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets:
-
Custom contract manufacturing per client requirements
-
Third-party manufacturing with branding and packaging options
-
Bulk production for domestic and international markets
-
WHO-GMP certified production ensuring quality and safety
Quality Assurance & Regulatory Compliance
Quality is paramount. Each batch of Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets undergoes:
Raw material testing
In-process monitoring
Final product quality analysis
All tablets are manufactured under WHO-GMP guidelines, ensuring safe, effective, and reliable antiretroviral therapy products for global distribution.
Why Choose Kureasia Pharma
WHO-GMP certified production for international compliance
Bulk manufacturing with flexible packaging options
Expertise in contract and third-party manufacturing
Timely delivery and regulatory support
Contact Us
Office Info
+91 95577 45784
+91 93110 19560
011-40234824
sales@kureasiapharma.com
B- 255,Third Floor, Munshi Ram Gupta Marg, Naraina Industrial Area Phase 1, New Delhi 110028
Industrial Area, Plot Number-1, Khasra No. 882, 883k, Village-Salempur, Mehdood-II, Haridwar 249402, INDIA
Let’s Discuss Your Requirements
Your Trusted Pharma Partner—From Formulation to Fulfillment
Join hands with Kureasia Pharma’s advanced production line for tablets, syrups, ointments, and more.
Copyright © 2025 Kureasia Pharma | Developed by OTD